JAN 30, 2016 11:05 PM PST

Therapy seeks and destroys prostate cancer in mice

A new therapy uses white blood cells to ferry cancer-killing proteins through the bloodstream. Tests show it virtually eliminates metastatic prostate cancer in mice.

“The therapy is remarkably effective in vivo and shows several advantages, such as no toxicity and getting good results in very low dosages,” says senior author Michael King, professor of biomedical engineering at Cornell University. “It was our wildest dream to completely prevent the spread of prostate cancer. And that’s what happened in this system.”
 
A single dose of the experimental therapy-even delivered very late in the course of the disease-dramatically reduced the number of tumor cells. "This suggests that it may never be too late to help," says Michael King.

Metastasis is the spread of cancer cells from one tumor to other organs of the body, such as the lungs, the liver, the spleen, and the kidneys. While surgery and radiation treat primary tumors, it remains difficult to detect and reach metastatic cancer cells—which makes the treatment of spreading cancer more treacherous and problematic, King says.

Researchers created nano-sized liposomes with a protein that attaches to leukocytes (white blood cells). The liposomes are about one-one hundredth the size of the white blood cells. As the white blood cells travel throughout the bloodstream, the hitchhiking protein kills the tumor cells—leaving the bloodstream free of cancer.

As reported in the study, published in the Journal of Controlled Release, prostate cancer cells were implanted into the prostate of male mice to let the tumors grow. The treatment prevented secondary tumors, and the primary tumor shrunk in size.

While treated mice showed no metastases, the circulating tumor cell count remained greatly reduced but not completely zero, which leads scientists to believe “you don’t have to be perfect in completely eliminating circulating tumor cells to observe a very good outcome,” King says.

Further, the researchers discovered that a single dose of the therapy—even delivered very late in the course of the disease—can substantially reduce the number of tumor cells. “This suggests that it may never be too late to help,” King says.

The National Cancer Institute funded the research.

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
JUL 31, 2018
Cancer
JUL 31, 2018
Can Medicine Prevent Cisplatin-associated Hearing Loss for Pediatric Cancer Patients?
Researchers have determined that sodium thiosulfate's antioxidant properties can prevent hearing loss in pediatric cancer patients being treated with Cisplatin....
AUG 14, 2018
Cancer
AUG 14, 2018
Can Zika Virus Help Neuroblastoma Patients?
Researchers in Florida published the potential for Zika virus to help in the treatment of Neuroblastoma in patients of all ages....
NOV 23, 2018
Health & Medicine
NOV 23, 2018
Fatty NK Cells Can't Target Cancer
Scientists have found yet another link between obesity and cancer. Obesity has long been known to increase the risk of coronary heart disease, stroke, type...
DEC 03, 2018
Cancer
DEC 03, 2018
Using bubbly nano-particles for chemotherapy delivery
We have all heard about the harsh side effects of chemotherapy that could be so difficult leading to stopping treatment. The reason behind those side effects is that chemotherapy drugs do tar...
DEC 09, 2018
Health & Medicine
DEC 09, 2018
Health Beliefs That Influence Skin Cancer
  In the U.S., there are over 3.5 million cases of skin cancer reported every year. Basal cell carcinoma and squamous cell carcinoma are the most comm...
DEC 11, 2018
Cancer
DEC 11, 2018
Biosensors developed that can detect cancer's metastatic ability
Researchers in University of California San Diego School of Medicine have developed a biosensor that can detect whether a cancer cell will spread in the future or not, which will help in deve...
Loading Comments...